Unprecedented Efficacy of CGRP Inhibitors for Migraine

preview_player
Показать описание
Experts discuss the use of monoclonal antibodies targeting calcitonin gene-related peptide as preventive therapy for migraine and the encouraging efficacy of these agents, as well as results in clinical practice that appear to surpass those seen in the phase 3 trials.
  1. NeurologyLive
Рекомендации по теме
Unprecedented Efficacy of 0:07:36

Unprecedented Efficacy of CGRP Inhibitors for Migraine

Real-world data suggests 0:04:34

Real-world data suggests that adding CGRP inhibitors to onabotulinumtoxinA adds efficacy

CGRP Inhibitors as 0:04:25

CGRP Inhibitors as Preventative Migraine Therapy

Efficacy and safety 0:01:24

Efficacy and safety of CGRP-directed antibodies in migraine

CGRP Inhibitors as 0:04:25

CGRP Inhibitors as Preventative Migraine Therapy

Development of Oral 0:07:26

Development of Oral CGRP Molecule Inhibitors for Acute Migraine

Real-world data on 0:08:29

Real-world data on anti-CGRP monoclonal antibodies

CGRP Inhibitors: Transformative 0:06:59

CGRP Inhibitors: Transformative Therapy for Migraine

Is the CGRP 0:02:52

Is the CGRP ligand or receptor a better target in migraine?

Real-world studies show 0:03:19

Real-world studies show effectiveness of anti-CGRP mAbs in difficult to treat patients with migraine

Migraine Prevention: New 0:56:52

Migraine Prevention: New Opportunities for Pain Relief

Considerations for Using 0:05:28

Considerations for Using CGRP Receptor Antagonists for Migraine

What are CGRP 0:00:43

What are CGRP Inhibitors for Migraine? Calcitonin Gene-Related Peptide

MasterClass on CGRP 0:19:54

MasterClass on CGRP Antagonist in Migraine

Response to CGRP 0:07:33

Response to CGRP Inhibitors: Refractory Migraine & Drug Overuse

Optimizing the Use 0:03:24

Optimizing the Use of CGRP Inhibitors in Migraine

Christopher Gottschalk, MD: 0:01:56

Christopher Gottschalk, MD: Long-Term Safety in Preventive Migraine Therapies

Dr Stephen Silberstein 0:00:30

Dr Stephen Silberstein on How Patients Are Reacting to CGRP Inhibitors

Dosage and Administration 0:06:44

Dosage and Administration of the Anti-CGRP Monoclonal Antibodies for Migraine

The Role of 0:05:05

The Role of CGRP as Targeted Treatment for Migraine - Module 5: ALD403

The updated guidelines 0:04:44

The updated guidelines for treating migraines with CGRP-targeted monoclonal antibodies

Safety of CGRP 0:06:15

Safety of CGRP Inhibitors for Migraine

Jessica Ailani, MD: 0:02:57

Jessica Ailani, MD: Long-Term Safety and Efficacy of Ubrogepant in Acute Migraine

For or against? 0:04:05

For or against? Anti-CGRP monoclonal antibodies as a first-line therapy for migraines

Комментарии
Автор

I can tell you for a fact from experience that these new injections

jacobaquilio